News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors
Photo of Devika Das from X
Jun 28, 2024, 12:37

Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors

Devika Das, Medical Director at Parexel, recently shared on LinkedIn:   .

“It definitely takes a village. With the advent of check point inhibitors there is a whole new Pandora’s box of toxicities and we need all our teams involved in patient care, engaged and educated on early recognition!
Check out our latest publication in the MMI series!”

Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors

Read further.
Source: Devika Das/LinkedIn

cancer cancer treatment Check point Inhibitors Devika Das early recognition immunotherapy Medical Research MMI series OncoDaily Oncology parexel patient care publication team involvement toxicities
Special Coverage
Science
Jan 6, 2025, 13:02
Max Julvé: Toxicity management strategies for solid tumour cell therapy
Science
Jan 6, 2025, 12:59
Arndt Vogel: The use of immunotherapy pre-liver transplant
Science
Jan 6, 2025, 12:40
Chaitanya Bandlamudi: Detailed clinico-genomic landscape of pancreatic adenocarcinomas
Science
Jan 6, 2025, 12:37
Sharlene Gill: Adjuvant immunotherapy in patients with resected ESO/GEJ cancer
Career
Jan 6, 2025, 12:35
Kicking of exciting new season of Inside Cancer Careers with LeeAnn Bailey - Train at NCI
Blog
Jan 6, 2025, 12:33
Revolutionizing Cancer Care - Canary Oncoceutics
Blog
Jan 6, 2025, 12:31
Banu Arun: Pioneering New Horizons in BRCA-Positive Breast Cancer Treatment
Blog
Jan 6, 2025, 12:31
Raising Radon Awareness - ALCSI
Insight
Jan 6, 2025, 12:28
We are proud to be the first non-profit 100% dedicated to Myelodysplastic Syndromes - MDS Foundation
Insight
Jan 6, 2025, 12:15
Erman Akkus: Adjuvant pembrolizumab after surgery in high risk muscle invasive bladder cancer
Blog
Jan 6, 2025, 11:56
Julie Gerberding: Extermely fortunate to benefit from Ellen Sigal’s passionate leadership as a member of FNIH Board
Blog
Jan 6, 2025, 11:54
Pashtoon Kasi: Have to be mindful of rare side effects of Immunotherapy